196 related articles for article (PubMed ID: 22361111)
1. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
2. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
[TBL] [Abstract][Full Text] [Related]
3. Engineering a synthetic cell panel to identify signalling components reprogrammed by the cell growth regulator anterior gradient-2.
Gray TA; Alsamman K; Murray E; Sims AH; Hupp TR
Mol Biosyst; 2014 Jun; 10(6):1409-25. PubMed ID: 24710632
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.
Chevet E; Fessart D; Delom F; Mulot A; Vojtesek B; Hrstka R; Murray E; Gray T; Hupp T
Oncogene; 2013 May; 32(20):2499-509. PubMed ID: 22945652
[TBL] [Abstract][Full Text] [Related]
5. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.
Fessart D; Robert J; Hartog C; Chevet E; Delom F; Babin G
J Exp Clin Cancer Res; 2021 Aug; 40(1):271. PubMed ID: 34452625
[TBL] [Abstract][Full Text] [Related]
6. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
7. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
8. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
[TBL] [Abstract][Full Text] [Related]
9. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
[TBL] [Abstract][Full Text] [Related]
10. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration.
Park K; Chung YJ; So H; Kim K; Park J; Oh M; Jo M; Choi K; Lee EJ; Choi YL; Song SY; Bae DS; Kim BG; Lee JH
Exp Mol Med; 2011 Feb; 43(2):91-100. PubMed ID: 21200134
[TBL] [Abstract][Full Text] [Related]
11. The role of AGR2 and AGR3 in cancer: similar but not identical.
Obacz J; Takacova M; Brychtova V; Dobes P; Pastorekova S; Vojtesek B; Hrstka R
Eur J Cell Biol; 2015; 94(3-4):139-47. PubMed ID: 25666661
[TBL] [Abstract][Full Text] [Related]
12. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
Salmans ML; Zhao F; Andersen B
Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee WS; Park SY; Park YL; Joo YE
In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
[TBL] [Abstract][Full Text] [Related]
14. AGR2-AGR3 hetero-oligomeric complexes: Identification and characterization.
Černocká H; Vonka P; Kasalová V; Sommerova L; Vandova V; Hrstka R; Ostatna V
Bioelectrochemistry; 2021 Aug; 140():107808. PubMed ID: 33848875
[TBL] [Abstract][Full Text] [Related]
15. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling.
Chi J; Zhang H; Hu J; Song Y; Li J; Wang L; Wang Z
Cell Signal; 2020 Jan; 65():109419. PubMed ID: 31526829
[TBL] [Abstract][Full Text] [Related]
16. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C
Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467
[TBL] [Abstract][Full Text] [Related]
17. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human anterior gradient protein 3.
Nguyen VD; Biterova E; Salin M; Wierenga RK; Ruddock LW
Acta Crystallogr F Struct Biol Commun; 2018 Jul; 74(Pt 7):425-430. PubMed ID: 29969106
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of genomic and transcriptomic alterations of
Fessart D; Villamor I; Chevet E; Delom F; Robert J
Open Biol; 2022 Jul; 12(7):220068. PubMed ID: 35857928
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
